o2h ChaiTime Portfolio Pitch Day – Cambridge Jan’26 Edition
o2h ChaiTime Portfolio Pitch Day – Fund Launch Series 23 January 2026 | Live on Zoom Hosted by o2h Ventures, a Cambridge-based specialist biotech fund manager deeply embedded in the..
o2h ChaiTime Portfolio Pitch Day – Fund Launch Series 23 January 2026 | Live on Zoom Hosted by o2h Ventures, a Cambridge-based specialist biotech fund manager deeply embedded in the..
Join Bio-EV for an evening of complimentary beer, wine, and food while seeing the latest scientific technologies from leading suppliers. REGISTER» Hosted by:
Biopharma strategy encompasses multiple areas that facilitate a company’s decision-making in drug development, commercialization, and overall business success in a highly competitive and regulated environment. In this workshop, seasoned biopharma..
This workshop will cover all key functions of Chemistry, Manufacturing and Control (CMC) of recombinant protein and antibody therapeutics. Designed for both experts seeking cross-functional insights and new entrants from..
Open House event for STEM educators! Join us on Sunday, February 22nd, 2026 at our Oakland warehouse. We invite all STEM educators to collect lab supplies, for your accredited school..
Join this free 1-hour webinar to explore the unique challenges of lyophilizing cytotoxic agents and antibodies individually, followed by an in-depth look at the complexities of lyophilizing antibody-drug conjugates (ADCs)...
Taking an early proof of concept into preclinical and clinical development is a costly and complex process. But there are strategic ways to streamline the process and reduce risk and..
We’d love to have you join us for a special milestone at Avid Bioservices—the grand opening of our new Early-Phase Center of Excellence in Costa Mesa. This new facility represents..
Clinical pharmacology continues to advance through innovative approaches that enhance drug development efficiency and decision-making. This session will highlight the expanding role of quantitative methods across the development spectrum—from first-in-human..